Used primarily as a synthetic intermediate in pharmaceutical research, this compound plays a key role in the development of kinase inhibitors and other biologically active molecules. Its halogenated indazole structure makes it valuable in medicinal chemistry for constructing drug candidates targeting inflammation, cancer, and central nervous system disorders. The bromo and fluoro substituents allow for further functionalization via cross-coupling reactions, enabling rapid diversification during lead optimization. It is also employed in the synthesis of selective enzyme modulators due to its favorable binding properties with certain protein targets.